Solubilization of various benzodiazepines for intranasal administration, a pilot study

Pharmaceutical Development and Technology

Volumn 2, Issue 3, 1997, Pages 293-296

  Bechgaard, Erik ^a   Gizurarson, Sveinbjörn ^b   Hjortkjær, Rolf K ^c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF ICELAND   (Iceland)

^c ATV   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; DIAZEPAM; DRUG VEHICLE; FLUNITRAZEPAM; LORAZEPAM; LORMETAZEPAM; MACROGOL; MIDAZOLAM; NITRAZEPAM; PROPYLENE GLYCOL; TRIAZOLAM;

ARTICLE; DOSE CALCULATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; INTRANASAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SEIZURE;

EID: 0031393881     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459709031449     Document Type: Article

References (19)

1. J. E. F. Reynolds, ed., Martindale, The Extra Pharmacopoeia, The Pharmaceutical Press, London, 1993.
2. R. S. Lott, Seizure disorders, in Applied Therapeutics. The Clinical Use of Drugs (L. Y. Young and M. A. Koda-Kimble, eds.), Applied Therapeutics, Washington, 1990, pp. 1369-1396.
3. M. A. K. Mattila and M. Suistomaa, Intravenous premedication with diazepam, Anaesthesia, 39, 879 (1984).
4. D. E. Langdon, Thrombophlebitis following diazepam, JAMA, 225, 1389 (1973).
5. A. T. Florence and D. Attwood, Drug interactions and incompatibilities - A physicochemical view, in Physico-chemical Principles of Pharmacy (A. T. Florence and D. Attwood, eds.), Macmillan Press, Houndmills, UK, 1988, pp, 407-454.
6. nd ed., Marcel Dekker, New York, 1994, pp, 229-268.
7. Y. W. Chien and S. -F. Chang, Intranasal drug delivery for systemic medication, Crit. Rev. Ther. Carrier Syst., 4, 67-194 (1987).
8. S. Gizurarson, The relevance of nasal physiology to the design of drug absorption studies, Adv. Drug Deliv. Rev., 11, 329-347 (1993).
9. N. C. T. Wilton, J. Leigh, D. R. Rosen, and U. A. Pandit, Preanesthetic sedation of preschool children using intranasal midazolam, Anesthesiology, 69, 972-975 (1988).
10. A. Louon and V. G. Reddy, Nasal midazolam and ketamine for paediatric sedation during computerised tomography, Acta Anesthesiol. Scand., 38, 259-261 (1994).
11. C. Y. Lui, G. L. Amidon, and A. Goldberg, Intranasal absorption of flurazepam, midazolam, and triazolam in dogs, J. Pharm. Sci., 80, 1125-1129 (1991).
12. A. H. Gouldberg, Nasal administration of benzodiazepine hypnotics, Eur. Patent Application no. 0386232B1.
13. S. W. J. Lau and J. T. Slattery, Absorption of diazepam and lorazepam following intranasal administration, Int. J. Pharm., 54, 171-174 (1989).
14. M. W. G. Schols-Hendriks, J. J. H. M. Lohman, R. Janknegt, J. J. Korten, F. W. H. M. Merkus, and P. M. Hooymans, Absorption of clonazepam after intranasal and buccal administration, Br. J. Clin. Pharmac., 39, 449-451 (1995).
15. H. Spiegelberg, R. Schläpfer, G. Zbinden, and A. Studer, Ein neues injizierbares lösnungsmittel (Glycofurol), Arzneittelforschung, 6, 75 (1956).
16. E. Bechgaard, S. Gizurarson, and R. K. Hjortkjær, A pharmaceutical preparation, Patent no. PCT/DK91/ 00119, 1991.
17. E. Taubøll, S. Lindström, W. Klem, and L. Gjerstad, A new injectable carbamazepine solution - antiepileptic effects and pharmaceutical properties, Epilepsy Res., 7, 59-64 (1990).
18. 10 in the rat after intravenous administration by a microsphere delivery system or in a new type of solution, Int. J. Tissue Reac., X, 99-102 (1988).
19. R. W. Bury, K. J. Breen, P. V. Desmond, K. Raymond, and M. L. Mashford, Disposition of intravenous glycofurol: effect of hepatic cirrhosis, Clin. Pharm. Ther., 36, 82 (1984).